June 25th 2025
Marketed as Orlynvah, oral sulopenem from Iterum Therapeutics was FDA approved last fall for uncomplicated urinary tract infections and has shown efficacy against infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.
Researchers Identify Risk Factors for Antibiotic Failure Among Pneumonia Patients
May 30th 2017Research presented at the 2017 American Thoracic Society International Conference reports that treatment with antibiotics failed in 1 in 4 adult patients who present with community-acquired pneumonia in the outpatient setting.
Read More
How Antibiotics Impact C. difficile rates
May 21st 2017Gonzalo Bearman, MD, MPH, professor of medicine, and hospital epidemiologist, Department of Internal Medicine and Infectious Diseases, Virginia Commonwealth University, explains how controlling antibiotic use can impact Clostridium difficile rates.
Watch